{"id":"nasonex-nasal-spray","safety":{"commonSideEffects":[{"rate":"10-15","effect":"Headache"},{"rate":"5-10","effect":"Pharyngitis"},{"rate":"5-8","effect":"Epistaxis"},{"rate":"3-5","effect":"Nasal irritation"},{"rate":"2-4","effect":"Dysgeusia"}]},"_chembl":{"chemblId":"CHEMBL14012","moleculeType":"Small molecule","molecularWeight":"218.30"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Mometasone furoate is a potent topical corticosteroid that suppresses local inflammatory responses in the nasal mucosa. It inhibits the release of inflammatory mediators (cytokines, chemokines, adhesion molecules) and reduces recruitment of inflammatory cells, thereby decreasing nasal congestion, rhinorrhea, and sneezing associated with allergic rhinitis.","oneSentence":"Nasonex (mometasone furoate) is a intranasal corticosteroid that reduces inflammation in the nasal passages by binding to glucocorticoid receptors.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:50:19.926Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Allergic rhinitis (seasonal and perennial)"},{"name":"Nasal polyps"}]},"trialDetails":[{"nctId":"NCT06914908","phase":"PHASE2","title":"Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Study","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-05-12","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":64},{"nctId":"NCT06834347","phase":"PHASE3","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-02-12","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":210},{"nctId":"NCT06834360","phase":"PHASE3","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-02-06","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":210},{"nctId":"NCT06439381","phase":"PHASE2","title":"Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps","status":"RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2024-07-16","conditions":"Chronic Rhinosinusitis","enrollment":120},{"nctId":"NCT06454240","phase":"PHASE2","title":"A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2024-07-17","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":79},{"nctId":"NCT04898764","phase":"PHASE4","title":"Research on Underlying Causes of Long-term Use of Nasal Decongestants and the Structured Withdrawal of the Decongestant","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2020-10-21","conditions":"Rhinitis Medicamentosa","enrollment":72},{"nctId":"NCT06451640","phase":"PHASE2","title":"A Extension Clinical Study of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.","startDate":"2024-07-04","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":59},{"nctId":"NCT06691113","phase":"PHASE2","title":"A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2024-12-16","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":60},{"nctId":"NCT06013241","phase":"PHASE2","title":"A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)","status":"COMPLETED","sponsor":"Insmed Incorporated","startDate":"2023-10-30","conditions":"Chronic Rhinosinusitis Without Nasal Polyps","enrollment":288},{"nctId":"NCT05382494","phase":"PHASE4","title":"Intranasal Steroid as Medical Therapy For Sleep-Disordered Breathing in Children","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2022-12-05","conditions":"Sleep Disorder; Breathing-Related, Snoring, Obstructive Sleep Apnea of Child","enrollment":130},{"nctId":"NCT07174115","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps","status":"RECRUITING","sponsor":"Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.","startDate":"2025-08-18","conditions":"Chronic Sinusitis Without Nasal Polyps","enrollment":30},{"nctId":"NCT07114107","phase":"NA","title":"Vibroacoustic Therapy With Oscillating Positive Expiratory Pressure in the Treatment of Nasal Congestion","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-08","conditions":"Atopic Rhinitis, Atopic Asthma","enrollment":200},{"nctId":"NCT06436534","phase":"NA","title":"Efficacy and Safety of Ganciclovir Capsules in the Treatment of Refractory Moderate-to-severe Allergic Rhinitis","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2024-05-24","conditions":"Rhinitis, Allergic","enrollment":50},{"nctId":"NCT03705793","phase":"PHASE4","title":"Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-01-01","conditions":"Chronic Rhinosinusitis (Diagnosis), Allergic Rhinosinusitis, Chronic Eosinophilic Rhinosinusitis","enrollment":53},{"nctId":"NCT07016763","phase":"EARLY_PHASE1","title":"Combination of Oral Supplement With Fatty Acids, Vitamin B6, Perilla, and Liquorice With Nasal Steroids for the Treatment of Allergic Rhinitis","status":"COMPLETED","sponsor":"Isola Tiberina - Gemelli Isola Hospital, Rome, Italy","startDate":"2024-09-01","conditions":"Allergic Rhinitis","enrollment":400},{"nctId":"NCT06036927","phase":"PHASE2","title":"A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2023-12-08","conditions":"Chronic Sinusitis, Nasal Polyps","enrollment":80},{"nctId":"NCT05902325","phase":"PHASE4","title":"Identifying Predictors Of Response To Mepolizumab In CRSwNP","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2023-10-03","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":36},{"nctId":"NCT04596189","phase":"PHASE4","title":"Dupilumab for Prevention of Recurrence of CRSwNP After ESS","status":"COMPLETED","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2021-05-25","conditions":"Chronic Rhinosinusitis With Nasal Polyps","enrollment":30},{"nctId":"NCT06801353","phase":"PHASE4","title":"A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal Polyps","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tongren Hospital","startDate":"2025-02-01","conditions":"Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Biological Therapy, Biomarkers","enrollment":90},{"nctId":"NCT00070707","phase":"PHASE4","title":"Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-04-03","conditions":"Rhinitis, Allergic, Seasonal, Asthma","enrollment":188},{"nctId":"NCT06573164","phase":"","title":"Allergic Rhinitis With/Without Asthma: Pre- and Post-Qipian Analysis","status":"COMPLETED","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2024-01-01","conditions":"Rhinitis, Allergic, Asthma","enrollment":60},{"nctId":"NCT00779740","phase":"PHASE3","title":"Equivalency Study of Two Formulations of Mometasone Furoate Nasal Spray (Study P04419)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-02-01","conditions":"Rhinitis, Allergic, Perennial","enrollment":102},{"nctId":"NCT00817050","phase":"PHASE4","title":"Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04207)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-12-01","conditions":"Allergic Rhinitis","enrollment":100},{"nctId":"NCT00779545","phase":"PHASE2","title":"A Study of Mometasone Furoate Nasal Spray in Perennial Allergic Rhinitis (Study P03748)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-04-08","conditions":"Rhinitis, Allergic, Perennial","enrollment":455},{"nctId":"NCT00834119","phase":"PHASE4","title":"Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-09-01","conditions":"Rhinitis, Allergic","enrollment":72},{"nctId":"NCT00732368","phase":"PHASE3","title":"A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-05-01","conditions":"Perennial Allergic Rhinitis","enrollment":98},{"nctId":"NCT00750750","phase":"PHASE2","title":"Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Study P02683)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-01-01","conditions":"Acute Rhinosinusitis","enrollment":981},{"nctId":"NCT00731185","phase":"PHASE3","title":"Mometasone Furoate Nasal Spray for Treatment of Nasal Polyposis After Surgery (Study P03218)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-09-01","conditions":"Nasal Polyps","enrollment":162},{"nctId":"NCT00783237","phase":"PHASE4","title":"Onset of Effect of Mometasone Nasal Spray in Induced Allergic Rhinitis (Study P03431)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-12-01","conditions":"Allergic Rhinitis","enrollment":340},{"nctId":"NCT00783458","phase":"PHASE4","title":"Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04208)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-12-01","conditions":"Allergic Rhinitis","enrollment":100},{"nctId":"NCT00751075","phase":"PHASE3","title":"Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Phase 3 Study)(Study P02692)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-12-01","conditions":"Acute Rhinosinusitis","enrollment":981},{"nctId":"NCT01098071","phase":"PHASE4","title":"Nasonex (Mometasone Furoate Nasal Spray) in Adenoids Hypertrophy in Children (P04367)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-08-01","conditions":"Adenoids","enrollment":34},{"nctId":"NCT01135134","phase":"PHASE3","title":"Multicenter, Double-blind, Randomized, Placebo-controlled Study of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06332)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-06","conditions":"Rhinitis, Allergic, Perennial","enrollment":333},{"nctId":"NCT01165424","phase":"PHASE3","title":"A Study of Long-term Administration of Mometasone Furoate Nasal Spray in Pediatric Subjects With Perennial Allergic Rhinitis (Study P06333AM1)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-04","conditions":"Rhinitis, Allergic, Perennial","enrollment":80},{"nctId":"NCT00359216","phase":"PHASE4","title":"The Effects of Mometasone Furoate Nasal Spray in Subjects With Sleep-disordered Breathing (SDB) Associated With Perennial Allergic Rhinitis (Study P04726)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-05","conditions":"Perennial Allergic Rhinitis, Obstructive Sleep Apnea, Sleep Disorder","enrollment":30},{"nctId":"NCT00599027","phase":"PHASE3","title":"An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-05","conditions":"Allergic Rhinitis, Asthma","enrollment":51},{"nctId":"NCT00732381","phase":"PHASE3","title":"Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05529)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-08","conditions":"Allergic Rhinitis","enrollment":351},{"nctId":"NCT00733005","phase":"PHASE3","title":"Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05528)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-07","conditions":"Allergic Rhinitis","enrollment":324},{"nctId":"NCT01386125","phase":"PHASE3","title":"A Study of the Effectiveness and Safety of Mometasone Furoate Nasal Spray (MFNS, SCH 032088) for the Treatment of Nasal Polyps (P05604)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-06","conditions":"Nasal Polyps","enrollment":748},{"nctId":"NCT00423176","phase":"PHASE3","title":"The Study of Nasonex® Compared With Placebo for the Relief of Symptoms Associated With Acute Bacterial Sinusitis When Used With Antibiotics (Study P04824AM3)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2006-12","conditions":"Sinusitis","enrollment":237},{"nctId":"NCT00378378","phase":"PHASE3","title":"Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old (P04292)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-07","conditions":"Nasal Polyps","enrollment":127},{"nctId":"NCT00552032","phase":"PHASE3","title":"Efficacy and Safety of Mometasone Furoate Nasal Spray in Children With Adenoid Hypertrophy. SNORE Study (P05155)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-08-01","conditions":"Adenoids Hypertrophy","enrollment":132},{"nctId":"NCT00552110","phase":"PHASE2","title":"Study of Mometasone Furoate Nasal Spray and Oxymetazoline Nasal Spray Given Together Once A Day To Treat Seasonal Allergic Rhinitis (P04500)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-07","conditions":"Seasonal Allergic Rhinitis","enrollment":707},{"nctId":"NCT05919316","phase":"NA","title":"The Efficacy Of Rhinophototherapy Compared To Intranasal Corticosteroids On The Nasal Mucosa","status":"RECRUITING","sponsor":"National University of Malaysia","startDate":"2023-07-04","conditions":"Allergic Rhinitis","enrollment":40},{"nctId":"NCT06126952","phase":"PHASE2","title":"Azelastine Allergen Chamber - Onset of Action Study","status":"COMPLETED","sponsor":"MEDA Pharma GmbH & Co. KG","startDate":"2023-10-30","conditions":"Seasonal Allergic Rhinitis","enrollment":84},{"nctId":"NCT05038202","phase":"PHASE4","title":"Study of Bencycloquidium Bromide Nasal Spray in the Treatment of Moderate-severe Persistent Allergic Rhinitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yingu Pharmaceutical Co., Ltd","startDate":"2021-06-16","conditions":"Allergic Rhinitis","enrollment":450},{"nctId":"NCT06200766","phase":"PHASE3","title":"A Multicenter, Randomized, Double-blind, Three-arm, Parallel Clinical Endpoint Bioequivalence Study of Monometasone Furoate Nasal Spray in Patients With Seasonal Allergic Rhinitis","status":"UNKNOWN","sponsor":"Zheng Liu ENT","startDate":"2023-08-25","conditions":"Seasonal Allergic Rhinitis","enrollment":640},{"nctId":"NCT04085744","phase":"NA","title":"A Comparison Of Local Anesthetic Agents And Steroid On Tracheal Tube Cuff","status":"COMPLETED","sponsor":"Derince Training and Research Hospital","startDate":"2019-11-01","conditions":"Anesthesia Intubation Complication, Intubation Complication, Sore Throat","enrollment":91},{"nctId":"NCT05887843","phase":"PHASE1","title":"Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis","status":"TERMINATED","sponsor":"Sandoz","startDate":"2023-06-08","conditions":"Seasonal Allergic Rhinitis","enrollment":38},{"nctId":"NCT05590598","phase":"PHASE3","title":"Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis.","status":"COMPLETED","sponsor":"Sandoz","startDate":"2023-02-13","conditions":"Seasonal Allergic Rhinitis","enrollment":472},{"nctId":"NCT05626621","phase":"PHASE4","title":"Efficacy of Azelastine and Mometasone Irrigation in Comparison to Nasal Sprays in Patients With Chronic Rhinitis","status":"RECRUITING","sponsor":"Endeavor Health","startDate":"2022-11-23","conditions":"Chronic Rhinitis","enrollment":81},{"nctId":"NCT05311475","phase":"PHASE3","title":"Prospective, Randomized, Multinational, Multicenter, Double-blind, Placebo and Active Controlled Trial in 4 Parallel-groups of Patients Suffering From Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Sandoz","startDate":"2022-04-04","conditions":"Seasonal Allergic Rhinitis","enrollment":669},{"nctId":"NCT05912192","phase":"NA","title":"The Efficacy Of Elonide Nasal Corticosteroids In Managing Allergic Rhinitis","status":"COMPLETED","sponsor":"National University of Malaysia","startDate":"2022-02-24","conditions":"Allergic Rhinitis","enrollment":163},{"nctId":"NCT05639959","phase":"","title":"Efficacy and Safety of New Mometasone Furoate Nasal Spray Formulation in Acute Rhinosinusitis Patients: A Randomized Clinical Trial","status":"COMPLETED","sponsor":"Saffron Pharma","startDate":"2022-09-10","conditions":"Acute Rhinosinusitis","enrollment":20},{"nctId":"NCT05570383","phase":"PHASE2, PHASE3","title":"Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR","status":"UNKNOWN","sponsor":"People's Hospital of Anshun City of Guizhou Province","startDate":"2022-12-01","conditions":"Allergic Rhinitis","enrollment":60},{"nctId":"NCT03323866","phase":"PHASE3","title":"Mometasone vs Budesonide in CRS With Polyposis","status":"TERMINATED","sponsor":"Université de Sherbrooke","startDate":"2017-05-01","conditions":"Chronic Rhinosinusitis (Diagnosis), Nasal Polyposis","enrollment":36},{"nctId":"NCT04670653","phase":"PHASE3","title":"Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis","status":"WITHDRAWN","sponsor":"EMS","startDate":"2022-08-01","conditions":"Allergic Rhinitis","enrollment":""},{"nctId":"NCT02447614","phase":"","title":"Follow-up Studies of Primary Snoring(PS) and Obstructive Sleep Apnea Hypopnea Syndrome(OSAHS) in Chinese Children","status":"COMPLETED","sponsor":"Beijing Children's Hospital","startDate":"2014-11","conditions":"Obstructive Sleep Apnea Syndrome","enrollment":500},{"nctId":"NCT05390255","phase":"PHASE3","title":"Establishment of Precise Diagnosis and Treatment System for Refractory Chronic Rhinosinusitis","status":"UNKNOWN","sponsor":"Beijing Tongren Hospital","startDate":"2022-05-25","conditions":"Sinusitis","enrollment":87},{"nctId":"NCT02874144","phase":"PHASE2","title":"Anti-Inflammatory Agent in Sinusitis","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2016-06-20","conditions":"Nasal Polyps","enrollment":43},{"nctId":"NCT03688555","phase":"PHASE2","title":"A Study to Evaluate the Effect of ACT-774312 in Subjects With Bilateral Nasal Polyposis","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2018-10-19","conditions":"Bilateral Nasal Polyposis","enrollment":10},{"nctId":"NCT05129306","phase":"","title":"Impact of RYALTRIS® Nasal Spray on Patients' Reported Outcomes","status":"WITHDRAWN","sponsor":"Community and Patient Preference Research Pty Ltd","startDate":"2021-11-17","conditions":"Allergic Rhinitis","enrollment":""},{"nctId":"NCT05301647","phase":"","title":"Mometasone Furoate Nasal Spray in Italian Children","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2019-06-20","conditions":"Rhinitis, Allergic, Nasal Allergy, Allergy Pollen","enrollment":80},{"nctId":"NCT00553891","phase":"PHASE4","title":"Placebo-controlled Trial With Nasonex for Nasal Obstruction Secondary to Adenoids Hypertrophy in Children (P04367)(TERMINATED)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2006-05","conditions":"Nasal Obstruction, Adenoids Hypertrophy, Adenoidectomy","enrollment":""},{"nctId":"NCT00903721","phase":"","title":"Nasonex® Nasal Suspension 50 μg Long-term Designated Drug Use Investigation (Study P05876)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-11","conditions":"Allergic Rhinitis","enrollment":3806},{"nctId":"NCT03855189","phase":"PHASE3","title":"Safety and Efficacy of Mometasone Furoate (SCH 032088) vs Beclomethasone Dipropionate or Placebo in Seasonal Allergic Rhinitis (C93-013)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1993-08-23","conditions":"Seasonal Allergic Rhinitis","enrollment":345},{"nctId":"NCT00453063","phase":"PHASE3","title":"Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg Once Daily (QD) in the Treatment of Seasonal Allergic Rhinitis (Study P05067)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-03","conditions":"Seasonal Allergic Rhinitis","enrollment":426},{"nctId":"NCT00468312","phase":"PHASE3","title":"Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 mcg QD in the Treatment of Seasonal Allergic Rhinitis (Study P05106)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-03","conditions":"Seasonal Allergic Rhinitis","enrollment":429},{"nctId":"NCT03882047","phase":"PHASE3","title":"Mometasone Furoate Aqueous (MK-0887/SCH 032088) Nasal Spray vs Placebo and FLONASE® in Seasonal Allergic Rhinitis Patients (I94-001)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1994-08-11","conditions":"Rhinitis, Allergic, Seasonal","enrollment":313},{"nctId":"NCT03861559","phase":"PHASE3","title":"Onset of Action of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray Compared With Placebo in Seasonal Allergic Rhinitis (C93-184)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1994-03-30","conditions":"Rhinitis, Allergic, Seasonal","enrollment":201},{"nctId":"NCT03879772","phase":"PHASE3","title":"Dose-Ranging Study of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray in the Treatment of Children (Ages 6-11) With Seasonal Allergic Rhinitis (C95-161)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1996-03-12","conditions":"Rhinitis, Allergic, Seasonal","enrollment":679},{"nctId":"NCT03855228","phase":"PHASE3","title":"Safety and Efficacy of Mometasone Furoate Nasal Spray With the Addition of Loratadine Versus Placebo in Participants With Seasonal Allergic Rhinitis (C94-145)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"1995-03-01","conditions":"Rhinitis, Allergic","enrollment":704},{"nctId":"NCT00491504","phase":"PHASE4","title":"This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-02","conditions":"Seasonal Allergic Rhinitis","enrollment":310},{"nctId":"NCT00783224","phase":"PHASE3","title":"A Comparative Study of Mometasone Furoate Nasal Spray and Fluticasone Propionate Nasal Spray in Patients With Perennial Allergic Rhinitis (Study P04512)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-09","conditions":"Perennial Allergic Rhinitis","enrollment":351},{"nctId":"NCT00728416","phase":"PHASE3","title":"Study of Nasonex in the Relief of Nasal Congestion in Patients With Seasonal Allergic Rhinitis (Study P05583)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-08","conditions":"Allergic Rhinitis","enrollment":333},{"nctId":"NCT00358527","phase":"PHASE4","title":"Mometasone Furoate on Sleep Disturbances in Subjects With Seasonal Allergic Rhinitis (Study P04608) (COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-05","conditions":"Seasonal Allergic Rhinitis","enrollment":401},{"nctId":"NCT03614923","phase":"PHASE2","title":"Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)","status":"COMPLETED","sponsor":"AnaptysBio, Inc.","startDate":"2018-11-29","conditions":"Chronic Rhinosinusitis","enrollment":105},{"nctId":"NCT02588326","phase":"PHASE1","title":"Sensitivity of Pharmacokinetics to Differences in Particle Size Distribution of Suspension-based Nasal Sprays","status":"COMPLETED","sponsor":"University of Florida","startDate":"2018-09-21","conditions":"Hypersensitivity","enrollment":80},{"nctId":"NCT01673659","phase":"PHASE3","title":"A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Padagis LLC","startDate":"2012-08","conditions":"Seasonal Allergic Rhinitis","enrollment":1220},{"nctId":"NCT03401229","phase":"PHASE3","title":"Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2018-01-15","conditions":"Nasal Polyposis","enrollment":413},{"nctId":"NCT04179461","phase":"PHASE2","title":"Personalized Treatment Algorithms for Difficult-to-treat Asthma","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2018-03-16","conditions":"Asthma in Children","enrollment":21},{"nctId":"NCT03085797","phase":"PHASE3","title":"Effect of Mepolizumab in Severe Bilateral Nasal Polyps","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-05-25","conditions":"Nasal Polyps","enrollment":414},{"nctId":"NCT01038427","phase":"PHASE3","title":"A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Sandoz","startDate":"2009-12-02","conditions":"Rhinitis, Allergic, Seasonal","enrollment":795},{"nctId":"NCT02110654","phase":"PHASE4","title":"Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery","status":"COMPLETED","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2014-06","conditions":"Sinusitis, Nasal Polyps, Asthma","enrollment":50},{"nctId":"NCT04484493","phase":"PHASE3","title":"Corticosteroid Nasal Spray in COVID-19 Anosmia","status":"COMPLETED","sponsor":"Benha University","startDate":"2020-08-08","conditions":"Covid19, Anosmia","enrollment":100},{"nctId":"NCT02953379","phase":"PHASE3","title":"Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis","status":"WITHDRAWN","sponsor":"EMS","startDate":"2019-05","conditions":"Allergic Rhinitis","enrollment":""},{"nctId":"NCT02953366","phase":"PHASE3","title":"Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis","status":"WITHDRAWN","sponsor":"EMS","startDate":"2019-05","conditions":"Allergic Rhinitis","enrollment":""},{"nctId":"NCT02318303","phase":"PHASE2","title":"To Study GSP 301 in Patients With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2014-12","conditions":"Seasonal Allergic Rhinitis","enrollment":1111},{"nctId":"NCT01850823","phase":"PHASE3","title":"Clinical Equivalence Study of Mometasone Nasal Spray","status":"COMPLETED","sponsor":"Actavis Inc.","startDate":"2013-02","conditions":"Seasonal Allergic Rhinitis","enrollment":880},{"nctId":"NCT03590912","phase":"PHASE4","title":"Efficacy and Cost Analysis of Steroids in Treatment of Otitis Media With Effusion","status":"COMPLETED","sponsor":"Lumbini Medical College","startDate":"2018-09-05","conditions":"Otitis Media With Effusion","enrollment":160},{"nctId":"NCT03280550","phase":"PHASE3","title":"A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2017-11-15","conditions":"Nasal Polyps, Chronic Rhinosinusitis","enrollment":138},{"nctId":"NCT03280537","phase":"PHASE3","title":"A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2017-11-21","conditions":"Nasal Polyps, Chronic Rhinosinusitis","enrollment":127},{"nctId":"NCT02709538","phase":"PHASE3","title":"Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR)","status":"COMPLETED","sponsor":"Glenmark Specialty S.A.","startDate":"2016-04","conditions":"Perennial Allergic Rhinitis","enrollment":601},{"nctId":"NCT02898454","phase":"PHASE3","title":"Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-11-28","conditions":"Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)","enrollment":448},{"nctId":"NCT03463031","phase":"PHASE3","title":"Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Glenmark Specialty S.A.","startDate":"2018-03-16","conditions":"Seasonal Allergic Rhinitis (SAR)","enrollment":446},{"nctId":"NCT02478398","phase":"PHASE3","title":"Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2015-07-20","conditions":"Rhinitis, Allergic, Seasonal","enrollment":1025},{"nctId":"NCT02912468","phase":"PHASE3","title":"A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-12-05","conditions":"Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)","enrollment":276},{"nctId":"NCT02113267","phase":"PHASE2","title":"Mometasone-furoate for Treatment of Eosinophilic Esophagitis - a Randomized Placebo Controlled Study.","status":"TERMINATED","sponsor":"Mogens Bove","startDate":"2014-04","conditions":"Eosinophilic Esophagitis","enrollment":40},{"nctId":"NCT02631551","phase":"PHASE3","title":"Efficacy and Safety of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Seasonal Allergic Rhinitis (SAR)","status":"COMPLETED","sponsor":"Glenmark Specialty S.A.","startDate":"2016-03","conditions":"Seasonal Allergic Rhinitis","enrollment":1180},{"nctId":"NCT02291549","phase":"PHASE3","title":"S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps","status":"COMPLETED","sponsor":"Intersect ENT","startDate":"2014-12","conditions":"Chronic Sinusitis, Nasal Polyposis","enrollment":300}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Mometasone furoate nasal spray"],"phase":"phase_3","status":"active","brandName":"Nasonex Nasal Spray","genericName":"Nasonex Nasal Spray","companyName":"National University of Malaysia","companyId":"national-university-of-malaysia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Nasonex (mometasone furoate) is a intranasal corticosteroid that reduces inflammation in the nasal passages by binding to glucocorticoid receptors. Used for Allergic rhinitis (seasonal and perennial), Nasal polyps.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}